Diagnostic Use of Non-Invasive Intelligent Wearables for Veterinary Healthcare

Wearable non-invasive devices have emerged as useful tools for tracking physiological data from companion animals. By combining this data with machine learning techniques, it is possible to proactively detect disorders and prompt owners to seek medical attention. This research aims to asses the efficacy of this approach by using wearable devices for continuous monitoring and […]

Read More
Learning Legible Human-Robot Handovers

Object handovers, which involve the action of giving and receiving objects, are an integral task for human-robot collaboration. Current human-to-robot handover systems rely on learning from sampled human expert trajectory data [5]. These data are usually difficult to gather, as two humans must hand over many different objects while recording the human motion with a […]

Read More
L2M – SilicoLabs

SilicoLabs’ software revolutionizes psychology/neuroscience research by harnessing XR to create real-world simulations. Researchers import their 3D models, video, audio, images and creating dynamic interactions between them and the participant – all without writing a single line of code! Researchers determine which variables they want to track (e.g., number of times an object is picked up) […]

Read More
L2M – A handheld bioprinting platform for treating severe skin wounds

Our project focuses on developing a bioprinting technology for treating severe burns. We aim to reduce scarring and enhance skin regeneration, which can significantly improve the lives of burn victims. This technology has the potential to make a big difference in the medical field, but it’s a challenging journey, especially due to the strict regulations […]

Read More
L2M – UTI Diagnostics Market Research

Urinary tract infections (UTIs) are one of the most common bacterial infections globally, affecting millions of people each year. The inappropriate use of antibiotics for UTIs is a significant driver of antibiotic resistance, posing a grave threat to public health. Complicated UTIs, characterized by treatment failure, recurrent infections, and increased mortality, disproportionately affect vulnerable populations, […]

Read More
L2M – Small Molecule Targeting TDP-43 aggregation as new therapeutics for ALS

In this project, the team will build a strong business foundation for a startup vehicle ‘Neuropeutics Inc’ to conduct further R&D and commercialize a new effective treatment for neurodegenerative diseases, namely ALS and FTD. That is, the team will develop a sustainable business model, a financial budget, a funds raising plan and marketing material. The […]

Read More
L2M – Validating Perioperative Solutions with PrehabRx

Surgery places significant stress on the body, much like running a marathon does. However, while marathon runners rigorously train before their race, most Canadians are not preparing for surgeries. Not only does a wealth of data exist supporting the notion of “better in, better out”, when it comes to surgery outcomes, but being in a […]

Read More
L2M – NorthMiRs Market Research

NorthMiRs is developing nanotechnology-enabled gene therapies for the treatment of sepsis. We have determined microRNAs that are dysregulated in septic patients and packaged them into a stable, synthetic, and scalable lipid nanoparticle delivery vehicle. Our lead therapeutic, NM-001, a miRNA replacement therapy for sepsis-associated cardiomyopathy has been shown to be anti-inflammatory, anti-microbial and protects organs […]

Read More
L2M – EPAID Technology: EPilepsy AI-Driven Technology

EPAID Technology: EPilepsy AI-Driven Technology aims to automate electrophysiological signal processing practice to assist clinicians in the treatment of epilepsy. We will partner with Springboard, who provides strategically positioned resources to Atlantic Canadian universities and colleges alike, helping them transfer both knowledge and technology into the private sector.

Read More
L2M – Clinical Development of a Novel NanoString Assay Predicts Survival and Clinical Outcomes in Myelofibrosis Patients

Myelofibrosis is a chronic and life-threatening blood disease. There is a need for accurate risk stratification approaches to guide personalized medicine decisions for these patients. To address this need, we developed a non-invasive blood-based test that is cost-effective, scalable and accurate. Through the Lab2Market program we will explore the market and develop the business case […]

Read More
Towards an understanding of the Contemporary Engineering Profession: Occupational outcomes of engineering graduates by industry sector, gender, race, and location of training in Ontario

The range of contemporary engineering careers extend far beyond those closely tied to the traditional disciplines taught in engineering schools. Using Canadian Census 2021 data, this study will examine the occupational outcomes of engineering graduates residing in Ontario, with specific attention to the differences between industry sectors of employment and along lines of race, gender, […]

Read More
L2M- Remote Care: Empowering patients through Remote Self-administered Medical assessment.

“RemoteCare” is a novel initiative that empowers individuals to conduct part of their medical assessments independently via a user-friendly remote digital solution. By enabling self-assessments, it reduces physician workload, minimizes wait times, and ensures quicker access to medical assistance, especially in underserved areas. However, its progress hinges on gaining the trust of traditional healthcare providers, […]

Read More